Physician profile
Jonathan Chrispin
NPI 1871729244
$76,626.61
in general payments reported to CMS, 2019-2025
9 companies · $28K in 2025
The $28K reported for 2025 was more than what 91% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2021: $3,601 · 2022: $11K · 2023: $25K · 2024: $8,302 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $15K · Food and Beverage: $3,138 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,925.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,375.00 |
| Travel and Lodging | $14,795.29 |
| Food and Beverage | $3,138.41 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32,062.54 | 2023-2025 | General - Therapies, Farapulse, Versacross Access Solution |
| Abbott Laboratories | $25,955.09 | 2019-2025 | Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Biosense Webster, INC. | $15,325.68 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Atricure, INC. | $3,025.65 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novo Nordisk INC | $117.15 | 2022 | |
| Stryker Corporation | $59.50 | 2024 | Mako |
| Janssen Pharmaceuticals, INC | $31.76 | 2023 | Xarelto |
| Cardiva Medical, INC. | $26.98 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Esperion Therapeutics, INC. | $22.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chrispin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.